Clearmind Medicine Inc. Increase Decrease Through Exercise Of Warrants Equity
Clearmind Medicine Inc. (CMND) reported Increase Decrease Through Exercise Of Warrants Equity of $429.76 thousand for the 3-month period ending 2026-01-31, per its 6-K filed 2026-03-12.
Financial Statements › Notes
ifrs-full:IncreaseDecreaseThroughExerciseOfWarrantsEquity · last filed 2026-03-12
CAD
| Period end | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|
| 2021-10-31 | 375.00K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Increase Decrease Through Exercise Of Warrants Equity 0 month | Increase Decrease Through Exercise Of Warrants Equity | Increase Decrease Through Exercise Of Warrants Equity 3 month | Increase Decrease Through Exercise Of Warrants Equity 6 month | Increase Decrease Through Exercise Of Warrants Equity 9 month | Increase Decrease Through Exercise Of Warrants Equity 12 month |
|---|---|---|---|---|---|---|
| 2026-01-31 | $429.76K 6-K · filed 2026-03-12 | $429.76K derived: sum of 2 quarters · filed 2026-03-12 | $429.76K derived: sum of 3 quarters · filed 2026-03-12 | $429.76K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-10-31 | $0.00 derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $0.00 derived: sum of 2 quarters · filed 2026-01-20 | $0.00 derived: sum of 3 quarters · filed 2026-01-20 | $437.01K 20-F · filed 2026-01-20 | ||
| 2025-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $0.00 derived: sum of 2 quarters · filed 2025-09-11 | $437.01K 6-K · filed 2025-09-11 | $509.60K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-04-30 | $0.00 derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $437.01K 6-K · filed 2025-06-12 | $509.60K derived: sum of 3 quarters · filed 2026-03-12 | $950.02K derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2025-01-31 | $437.01K 6-K · filed 2026-03-12 | $509.60K derived: sum of 2 quarters · filed 2026-03-12 | $950.02K derived: sum of 3 quarters · filed 2026-03-12 | $1.17M derived: sum of 4 quarters · filed 2026-03-12 | ||
| 2024-10-31 | $72.59K derived: 20-F 12 month − 6-K 9 month · filed 2026-01-20 | $513.01K derived: sum of 2 quarters · filed 2026-01-20 | $735.50K derived: sum of 3 quarters · filed 2026-01-20 | $4.67M 20-F · filed 2026-01-20 | ||
| 2024-07-31 | $440.42K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $662.91K derived: sum of 2 quarters · filed 2025-09-11 | $4.59M 6-K · filed 2025-09-11 | |||
| 2024-04-30 | $222.49K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $4.15M 6-K · filed 2025-06-12 | ||||
| 2024-01-31 | $3.93M 6-K · filed 2025-03-13 | |||||
| 2023-10-31 | $1.16M 20-F · filed 2026-01-20 | |||||
| 2023-10-20 | $574.04K 20-F/A · filed 2024-03-18 | |||||
| 2023-09-24 | $26.15K 20-F/A · filed 2024-03-18 |